MEDINA, Almirall and UC3M to research new treatments for rare genetic diseases

MEDINA joins the global COVID-19 research effort looking for new therapeutics and diagnostic solutions for SARS-CoV-2.

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics

First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species.